PACS Group, Inc.

PACS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, PACS stands at 5.9B. In comparison, TPGXL has a market cap of 22.9B. Regarding current trading prices, PACS is priced at $37.48, while TPGXL trades at $24.35.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

PACS currently has a P/E ratio of 24.21, whereas TPGXL's P/E ratio is N/A. In terms of profitability, PACS's ROE is +0.27%, compared to TPGXL's ROE of +0.13%. Regarding short-term risk, PACS is more volatile compared to TPGXL. This indicates potentially higher risk in terms of short-term price fluctuations for PACS.Check TPGXL's competition here

PACS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, PACS stands at 5.9B. In comparison, VOYA has a market cap of 7.4B. Regarding current trading prices, PACS is priced at $37.48, while VOYA trades at $81.44.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

PACS currently has a P/E ratio of 24.21, whereas VOYA's P/E ratio is 12.30. In terms of profitability, PACS's ROE is +0.27%, compared to VOYA's ROE of +0.14%. Regarding short-term risk, PACS is more volatile compared to VOYA. This indicates potentially higher risk in terms of short-term price fluctuations for PACS.Check VOYA's competition here

PACS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, PACS stands at 5.9B. In comparison, VOYA-PB has a market cap of 7.3B. Regarding current trading prices, PACS is priced at $37.48, while VOYA-PB trades at $24.06.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

PACS currently has a P/E ratio of 24.21, whereas VOYA-PB's P/E ratio is 2.85. In terms of profitability, PACS's ROE is +0.27%, compared to VOYA-PB's ROE of +0.14%. Regarding short-term risk, PACS is more volatile compared to VOYA-PB. This indicates potentially higher risk in terms of short-term price fluctuations for PACS.Check VOYA-PB's competition here

PACS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, PACS stands at 5.9B. In comparison, BIPH has a market cap of 6B. Regarding current trading prices, PACS is priced at $37.48, while BIPH trades at $16.43.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

PACS currently has a P/E ratio of 24.21, whereas BIPH's P/E ratio is N/A. In terms of profitability, PACS's ROE is +0.27%, compared to BIPH's ROE of +0.03%. Regarding short-term risk, PACS is more volatile compared to BIPH. This indicates potentially higher risk in terms of short-term price fluctuations for PACS.Check BIPH's competition here

PACS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, PACS stands at 5.9B. In comparison, MSDL has a market cap of 1.3B. Regarding current trading prices, PACS is priced at $37.48, while MSDL trades at $15.24.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

PACS currently has a P/E ratio of 24.21, whereas MSDL's P/E ratio is 15.10. In terms of profitability, PACS's ROE is +0.27%, compared to MSDL's ROE of +0.05%. Regarding short-term risk, PACS is more volatile compared to MSDL. This indicates potentially higher risk in terms of short-term price fluctuations for PACS.Check MSDL's competition here

PACS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, PACS stands at 5.9B. In comparison, BBCQW has a market cap of 925.8M. Regarding current trading prices, PACS is priced at $37.48, while BBCQW trades at $1.60.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

PACS currently has a P/E ratio of 24.21, whereas BBCQW's P/E ratio is N/A. In terms of profitability, PACS's ROE is +0.27%, compared to BBCQW's ROE of N/A. Regarding short-term risk, PACS is less volatile compared to BBCQW. This indicates potentially lower risk in terms of short-term price fluctuations for PACS.Check BBCQW's competition here

PACS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, PACS stands at 5.9B. In comparison, RILYK has a market cap of 787.6M. Regarding current trading prices, PACS is priced at $37.48, while RILYK trades at $25.23.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

PACS currently has a P/E ratio of 24.21, whereas RILYK's P/E ratio is N/A. In terms of profitability, PACS's ROE is +0.27%, compared to RILYK's ROE of -2.63%. Regarding short-term risk, PACS is more volatile compared to RILYK. This indicates potentially higher risk in terms of short-term price fluctuations for PACS.Check RILYK's competition here

PACS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, PACS stands at 5.9B. In comparison, RILYN has a market cap of 774.8M. Regarding current trading prices, PACS is priced at $37.48, while RILYN trades at $24.82.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

PACS currently has a P/E ratio of 24.21, whereas RILYN's P/E ratio is N/A. In terms of profitability, PACS's ROE is +0.27%, compared to RILYN's ROE of -2.63%. Regarding short-term risk, PACS is more volatile compared to RILYN. This indicates potentially higher risk in terms of short-term price fluctuations for PACS.Check RILYN's competition here

PACS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, PACS stands at 5.9B. In comparison, RILYG has a market cap of 755.8M. Regarding current trading prices, PACS is priced at $37.48, while RILYG trades at $24.38.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

PACS currently has a P/E ratio of 24.21, whereas RILYG's P/E ratio is N/A. In terms of profitability, PACS's ROE is +0.27%, compared to RILYG's ROE of -2.63%. Regarding short-term risk, PACS is more volatile compared to RILYG. This indicates potentially higher risk in terms of short-term price fluctuations for PACS.Check RILYG's competition here

PACS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, PACS stands at 5.9B. In comparison, RILYM has a market cap of 753M. Regarding current trading prices, PACS is priced at $37.48, while RILYM trades at $25.11.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

PACS currently has a P/E ratio of 24.21, whereas RILYM's P/E ratio is N/A. In terms of profitability, PACS's ROE is +0.27%, compared to RILYM's ROE of -2.63%. Regarding short-term risk, PACS is more volatile compared to RILYM. This indicates potentially higher risk in terms of short-term price fluctuations for PACS.Check RILYM's competition here

PACS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, PACS stands at 5.9B. In comparison, RILYT has a market cap of 655.6M. Regarding current trading prices, PACS is priced at $37.48, while RILYT trades at $21.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

PACS currently has a P/E ratio of 24.21, whereas RILYT's P/E ratio is N/A. In terms of profitability, PACS's ROE is +0.27%, compared to RILYT's ROE of -2.63%. Regarding short-term risk, PACS is more volatile compared to RILYT. This indicates potentially higher risk in terms of short-term price fluctuations for PACS.Check RILYT's competition here

PACS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, PACS stands at 5.9B. In comparison, RILYO has a market cap of 573.5M. Regarding current trading prices, PACS is priced at $37.48, while RILYO trades at $25.13.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

PACS currently has a P/E ratio of 24.21, whereas RILYO's P/E ratio is N/A. In terms of profitability, PACS's ROE is +0.27%, compared to RILYO's ROE of -2.63%. Regarding short-term risk, PACS is more volatile compared to RILYO. This indicates potentially higher risk in terms of short-term price fluctuations for PACS.Check RILYO's competition here

PACS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, PACS stands at 5.9B. In comparison, NWAX has a market cap of 502M. Regarding current trading prices, PACS is priced at $37.48, while NWAX trades at $10.08.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

PACS currently has a P/E ratio of 24.21, whereas NWAX's P/E ratio is N/A. In terms of profitability, PACS's ROE is +0.27%, compared to NWAX's ROE of +0.01%. Regarding short-term risk, PACS is more volatile compared to NWAX. This indicates potentially higher risk in terms of short-term price fluctuations for PACS.Check NWAX's competition here

PACS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, PACS stands at 5.9B. In comparison, RILYL has a market cap of 484.4M. Regarding current trading prices, PACS is priced at $37.48, while RILYL trades at $15.67.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

PACS currently has a P/E ratio of 24.21, whereas RILYL's P/E ratio is 2.61. In terms of profitability, PACS's ROE is +0.27%, compared to RILYL's ROE of -2.63%. Regarding short-term risk, PACS is less volatile compared to RILYL. This indicates potentially lower risk in terms of short-term price fluctuations for PACS.Check RILYL's competition here

PACS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, PACS stands at 5.9B. In comparison, RILYP has a market cap of 473.2M. Regarding current trading prices, PACS is priced at $37.48, while RILYP trades at $15.40.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

PACS currently has a P/E ratio of 24.21, whereas RILYP's P/E ratio is 2.55. In terms of profitability, PACS's ROE is +0.27%, compared to RILYP's ROE of -2.63%. Regarding short-term risk, PACS is more volatile compared to RILYP. This indicates potentially higher risk in terms of short-term price fluctuations for PACS.Check RILYP's competition here

PACS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, PACS stands at 5.9B. In comparison, CRAN has a market cap of 470.4M. Regarding current trading prices, PACS is priced at $37.48, while CRAN trades at $10.03.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

PACS currently has a P/E ratio of 24.21, whereas CRAN's P/E ratio is N/A. In terms of profitability, PACS's ROE is +0.27%, compared to CRAN's ROE of +0.01%. Regarding short-term risk, PACS is more volatile compared to CRAN. This indicates potentially higher risk in terms of short-term price fluctuations for PACS.Check CRAN's competition here

PACS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, PACS stands at 5.9B. In comparison, PLMKW has a market cap of 444.8M. Regarding current trading prices, PACS is priced at $37.48, while PLMKW trades at $0.60.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

PACS currently has a P/E ratio of 24.21, whereas PLMKW's P/E ratio is N/A. In terms of profitability, PACS's ROE is +0.27%, compared to PLMKW's ROE of +0.04%. Regarding short-term risk, PACS is more volatile compared to PLMKW. This indicates potentially higher risk in terms of short-term price fluctuations for PACS.Check PLMKW's competition here

PACS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, PACS stands at 5.9B. In comparison, CCXIU has a market cap of 432.4M. Regarding current trading prices, PACS is priced at $37.48, while CCXIU trades at $10.25.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

PACS currently has a P/E ratio of 24.21, whereas CCXIU's P/E ratio is N/A. In terms of profitability, PACS's ROE is +0.27%, compared to CCXIU's ROE of +0.00%. Regarding short-term risk, PACS is more volatile compared to CCXIU. This indicates potentially higher risk in terms of short-term price fluctuations for PACS.Check CCXIU's competition here

PACS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, PACS stands at 5.9B. In comparison, CCXI has a market cap of 430.7M. Regarding current trading prices, PACS is priced at $37.48, while CCXI trades at $10.28.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

PACS currently has a P/E ratio of 24.21, whereas CCXI's P/E ratio is N/A. In terms of profitability, PACS's ROE is +0.27%, compared to CCXI's ROE of +0.00%. Regarding short-term risk, PACS is more volatile compared to CCXI. This indicates potentially higher risk in terms of short-term price fluctuations for PACS.Check CCXI's competition here

PACS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, PACS stands at 5.9B. In comparison, BBCQ has a market cap of 396.7M. Regarding current trading prices, PACS is priced at $37.48, while BBCQ trades at $10.35.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

PACS currently has a P/E ratio of 24.21, whereas BBCQ's P/E ratio is N/A. In terms of profitability, PACS's ROE is +0.27%, compared to BBCQ's ROE of N/A. Regarding short-term risk, PACS is more volatile compared to BBCQ. This indicates potentially higher risk in terms of short-term price fluctuations for PACS.Check BBCQ's competition here

PACS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, PACS stands at 5.9B. In comparison, DBCAU has a market cap of 381.4M. Regarding current trading prices, PACS is priced at $37.48, while DBCAU trades at $10.04.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

PACS currently has a P/E ratio of 24.21, whereas DBCAU's P/E ratio is N/A. In terms of profitability, PACS's ROE is +0.27%, compared to DBCAU's ROE of N/A. Regarding short-term risk, PACS is more volatile compared to DBCAU. This indicates potentially higher risk in terms of short-term price fluctuations for PACS.Check DBCAU's competition here

PACS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, PACS stands at 5.9B. In comparison, ANSCU has a market cap of 369.2M. Regarding current trading prices, PACS is priced at $37.48, while ANSCU trades at $11.11.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

PACS currently has a P/E ratio of 24.21, whereas ANSCU's P/E ratio is N/A. In terms of profitability, PACS's ROE is +0.27%, compared to ANSCU's ROE of +0.04%. Regarding short-term risk, PACS is more volatile compared to ANSCU. This indicates potentially higher risk in terms of short-term price fluctuations for PACS.Check ANSCU's competition here

PACS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, PACS stands at 5.9B. In comparison, CXIIU has a market cap of 367.9M. Regarding current trading prices, PACS is priced at $37.48, while CXIIU trades at $10.12.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

PACS currently has a P/E ratio of 24.21, whereas CXIIU's P/E ratio is N/A. In terms of profitability, PACS's ROE is +0.27%, compared to CXIIU's ROE of N/A. Regarding short-term risk, PACS is more volatile compared to CXIIU. This indicates potentially higher risk in terms of short-term price fluctuations for PACS.Check CXIIU's competition here

PACS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, PACS stands at 5.9B. In comparison, NWAX-UN has a market cap of 363.3M. Regarding current trading prices, PACS is priced at $37.48, while NWAX-UN trades at $10.35.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

PACS currently has a P/E ratio of 24.21, whereas NWAX-UN's P/E ratio is N/A. In terms of profitability, PACS's ROE is +0.27%, compared to NWAX-UN's ROE of +0.01%. Regarding short-term risk, PACS is more volatile compared to NWAX-UN. This indicates potentially higher risk in terms of short-term price fluctuations for PACS.Check NWAX-UN's competition here

PACS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, PACS stands at 5.9B. In comparison, CRANU has a market cap of 361.8M. Regarding current trading prices, PACS is priced at $37.48, while CRANU trades at $10.22.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

PACS currently has a P/E ratio of 24.21, whereas CRANU's P/E ratio is N/A. In terms of profitability, PACS's ROE is +0.27%, compared to CRANU's ROE of +0.00%. Regarding short-term risk, PACS is more volatile compared to CRANU. This indicates potentially higher risk in terms of short-term price fluctuations for PACS.Check CRANU's competition here

PACS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, PACS stands at 5.9B. In comparison, SBXE has a market cap of 348M. Regarding current trading prices, PACS is priced at $37.48, while SBXE trades at $10.03.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

PACS currently has a P/E ratio of 24.21, whereas SBXE's P/E ratio is N/A. In terms of profitability, PACS's ROE is +0.27%, compared to SBXE's ROE of -0.03%. Regarding short-term risk, PACS is more volatile compared to SBXE. This indicates potentially higher risk in terms of short-term price fluctuations for PACS.Check SBXE's competition here

PACS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, PACS stands at 5.9B. In comparison, ARCI has a market cap of 340.5M. Regarding current trading prices, PACS is priced at $37.48, while ARCI trades at $9.94.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

PACS currently has a P/E ratio of 24.21, whereas ARCI's P/E ratio is -4317.39. In terms of profitability, PACS's ROE is +0.27%, compared to ARCI's ROE of +0.00%. Regarding short-term risk, PACS is more volatile compared to ARCI. This indicates potentially higher risk in terms of short-term price fluctuations for PACS.Check ARCI's competition here

PACS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, PACS stands at 5.9B. In comparison, RILY has a market cap of 334.5M. Regarding current trading prices, PACS is priced at $37.48, while RILY trades at $9.01.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

PACS currently has a P/E ratio of 24.21, whereas RILY's P/E ratio is 0.62. In terms of profitability, PACS's ROE is +0.27%, compared to RILY's ROE of -2.63%. Regarding short-term risk, PACS is less volatile compared to RILY. This indicates potentially lower risk in terms of short-term price fluctuations for PACS.Check RILY's competition here

PACS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, PACS stands at 5.9B. In comparison, SAC has a market cap of 318.4M. Regarding current trading prices, PACS is priced at $37.48, while SAC trades at $10.15.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

PACS currently has a P/E ratio of 24.21, whereas SAC's P/E ratio is N/A. In terms of profitability, PACS's ROE is +0.27%, compared to SAC's ROE of +0.00%. Regarding short-term risk, PACS is more volatile compared to SAC. This indicates potentially higher risk in terms of short-term price fluctuations for PACS.Check SAC's competition here

PACS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, PACS stands at 5.9B. In comparison, KBONU has a market cap of 309M. Regarding current trading prices, PACS is priced at $37.48, while KBONU trades at $10.30.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

PACS currently has a P/E ratio of 24.21, whereas KBONU's P/E ratio is N/A. In terms of profitability, PACS's ROE is +0.27%, compared to KBONU's ROE of +0.02%. Regarding short-term risk, PACS is more volatile compared to KBONU. This indicates potentially higher risk in terms of short-term price fluctuations for PACS.Check KBONU's competition here

PACS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, PACS stands at 5.9B. In comparison, DBCA has a market cap of 306.7M. Regarding current trading prices, PACS is priced at $37.48, while DBCA trades at $9.91.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

PACS currently has a P/E ratio of 24.21, whereas DBCA's P/E ratio is N/A. In terms of profitability, PACS's ROE is +0.27%, compared to DBCA's ROE of N/A. Regarding short-term risk, PACS is more volatile compared to DBCA. This indicates potentially higher risk in terms of short-term price fluctuations for PACS.Check DBCA's competition here

PACS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, PACS stands at 5.9B. In comparison, ALOVU has a market cap of 301.1M. Regarding current trading prices, PACS is priced at $37.48, while ALOVU trades at $10.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

PACS currently has a P/E ratio of 24.21, whereas ALOVU's P/E ratio is N/A. In terms of profitability, PACS's ROE is +0.27%, compared to ALOVU's ROE of +1.47%. Regarding short-term risk, PACS is more volatile compared to ALOVU. This indicates potentially higher risk in terms of short-term price fluctuations for PACS.Check ALOVU's competition here

PACS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, PACS stands at 5.9B. In comparison, PLMKU has a market cap of 293.4M. Regarding current trading prices, PACS is priced at $37.48, while PLMKU trades at $10.70.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

PACS currently has a P/E ratio of 24.21, whereas PLMKU's P/E ratio is N/A. In terms of profitability, PACS's ROE is +0.27%, compared to PLMKU's ROE of +0.04%. Regarding short-term risk, PACS is more volatile compared to PLMKU. This indicates potentially higher risk in terms of short-term price fluctuations for PACS.Check PLMKU's competition here

PACS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, PACS stands at 5.9B. In comparison, HACQ has a market cap of 286.4M. Regarding current trading prices, PACS is priced at $37.48, while HACQ trades at $9.97.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

PACS currently has a P/E ratio of 24.21, whereas HACQ's P/E ratio is N/A. In terms of profitability, PACS's ROE is +0.27%, compared to HACQ's ROE of N/A. Regarding short-term risk, PACS is more volatile compared to HACQ. This indicates potentially higher risk in terms of short-term price fluctuations for PACS.Check HACQ's competition here

PACS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, PACS stands at 5.9B. In comparison, ACAAU has a market cap of 286.1M. Regarding current trading prices, PACS is priced at $37.48, while ACAAU trades at $10.01.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

PACS currently has a P/E ratio of 24.21, whereas ACAAU's P/E ratio is N/A. In terms of profitability, PACS's ROE is +0.27%, compared to ACAAU's ROE of +1.52%. Regarding short-term risk, PACS is more volatile compared to ACAAU. This indicates potentially higher risk in terms of short-term price fluctuations for PACS.Check ACAAU's competition here

PACS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, PACS stands at 5.9B. In comparison, XCBE has a market cap of 278.6M. Regarding current trading prices, PACS is priced at $37.48, while XCBE trades at $9.91.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

PACS currently has a P/E ratio of 24.21, whereas XCBE's P/E ratio is N/A. In terms of profitability, PACS's ROE is +0.27%, compared to XCBE's ROE of +0.00%. Regarding short-term risk, PACS is more volatile compared to XCBE. This indicates potentially higher risk in terms of short-term price fluctuations for PACS.Check XCBE's competition here

PACS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, PACS stands at 5.9B. In comparison, XSLL has a market cap of 273.5M. Regarding current trading prices, PACS is priced at $37.48, while XSLL trades at $9.88.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

PACS currently has a P/E ratio of 24.21, whereas XSLL's P/E ratio is N/A. In terms of profitability, PACS's ROE is +0.27%, compared to XSLL's ROE of +0.00%. Regarding short-term risk, PACS is more volatile compared to XSLL. This indicates potentially higher risk in terms of short-term price fluctuations for PACS.Check XSLL's competition here

PACS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, PACS stands at 5.9B. In comparison, FACTU has a market cap of 272.1M. Regarding current trading prices, PACS is priced at $37.48, while FACTU trades at $11.45.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

PACS currently has a P/E ratio of 24.21, whereas FACTU's P/E ratio is N/A. In terms of profitability, PACS's ROE is +0.27%, compared to FACTU's ROE of +0.03%. Regarding short-term risk, PACS is more volatile compared to FACTU. This indicates potentially higher risk in terms of short-term price fluctuations for PACS.Check FACTU's competition here

PACS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, PACS stands at 5.9B. In comparison, HVII has a market cap of 271.2M. Regarding current trading prices, PACS is priced at $37.48, while HVII trades at $10.42.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

PACS currently has a P/E ratio of 24.21, whereas HVII's P/E ratio is 69.47. In terms of profitability, PACS's ROE is +0.27%, compared to HVII's ROE of +0.02%. Regarding short-term risk, PACS is more volatile compared to HVII. This indicates potentially higher risk in terms of short-term price fluctuations for PACS.Check HVII's competition here

PACS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, PACS stands at 5.9B. In comparison, MLAA has a market cap of 261M. Regarding current trading prices, PACS is priced at $37.48, while MLAA trades at $10.01.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

PACS currently has a P/E ratio of 24.21, whereas MLAA's P/E ratio is N/A. In terms of profitability, PACS's ROE is +0.27%, compared to MLAA's ROE of N/A. Regarding short-term risk, PACS is more volatile compared to MLAA. This indicates potentially higher risk in terms of short-term price fluctuations for PACS.Check MLAA's competition here

PACS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, PACS stands at 5.9B. In comparison, SORN has a market cap of 260.6M. Regarding current trading prices, PACS is priced at $37.48, while SORN trades at $9.91.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

PACS currently has a P/E ratio of 24.21, whereas SORN's P/E ratio is N/A. In terms of profitability, PACS's ROE is +0.27%, compared to SORN's ROE of +1.43%. Regarding short-term risk, PACS is more volatile compared to SORN. This indicates potentially higher risk in terms of short-term price fluctuations for PACS.Check SORN's competition here

PACS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, PACS stands at 5.9B. In comparison, GIXXU has a market cap of 260M. Regarding current trading prices, PACS is priced at $37.48, while GIXXU trades at $10.12.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

PACS currently has a P/E ratio of 24.21, whereas GIXXU's P/E ratio is N/A. In terms of profitability, PACS's ROE is +0.27%, compared to GIXXU's ROE of +0.00%. Regarding short-term risk, PACS is more volatile compared to GIXXU. This indicates potentially higher risk in terms of short-term price fluctuations for PACS.Check GIXXU's competition here

PACS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, PACS stands at 5.9B. In comparison, ALOV has a market cap of 259.2M. Regarding current trading prices, PACS is priced at $37.48, while ALOV trades at $9.91.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

PACS currently has a P/E ratio of 24.21, whereas ALOV's P/E ratio is N/A. In terms of profitability, PACS's ROE is +0.27%, compared to ALOV's ROE of N/A. Regarding short-term risk, PACS is more volatile compared to ALOV. This indicates potentially higher risk in terms of short-term price fluctuations for PACS.Check ALOV's competition here

PACS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, PACS stands at 5.9B. In comparison, PLMK has a market cap of 257.9M. Regarding current trading prices, PACS is priced at $37.48, while PLMK trades at $10.64.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

PACS currently has a P/E ratio of 24.21, whereas PLMK's P/E ratio is 40.92. In terms of profitability, PACS's ROE is +0.27%, compared to PLMK's ROE of +0.04%. Regarding short-term risk, PACS is more volatile compared to PLMK. This indicates potentially higher risk in terms of short-term price fluctuations for PACS.Check PLMK's competition here

PACS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, PACS stands at 5.9B. In comparison, HVIIU has a market cap of 257.8M. Regarding current trading prices, PACS is priced at $37.48, while HVIIU trades at $10.80.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

PACS currently has a P/E ratio of 24.21, whereas HVIIU's P/E ratio is N/A. In terms of profitability, PACS's ROE is +0.27%, compared to HVIIU's ROE of +0.02%. Regarding short-term risk, PACS is more volatile compared to HVIIU. This indicates potentially higher risk in terms of short-term price fluctuations for PACS.Check HVIIU's competition here

PACS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, PACS stands at 5.9B. In comparison, AACI has a market cap of 253.7M. Regarding current trading prices, PACS is priced at $37.48, while AACI trades at $9.94.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

PACS currently has a P/E ratio of 24.21, whereas AACI's P/E ratio is N/A. In terms of profitability, PACS's ROE is +0.27%, compared to AACI's ROE of +0.00%. Regarding short-term risk, PACS is more volatile compared to AACI. This indicates potentially higher risk in terms of short-term price fluctuations for PACS.Check AACI's competition here

PACS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, PACS stands at 5.9B. In comparison, PTOR has a market cap of 252.1M. Regarding current trading prices, PACS is priced at $37.48, while PTOR trades at $9.90.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

PACS currently has a P/E ratio of 24.21, whereas PTOR's P/E ratio is N/A. In terms of profitability, PACS's ROE is +0.27%, compared to PTOR's ROE of +0.00%. Regarding short-term risk, PACS is more volatile compared to PTOR. This indicates potentially higher risk in terms of short-term price fluctuations for PACS.Check PTOR's competition here

PACS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, PACS stands at 5.9B. In comparison, DMAAU has a market cap of 250.5M. Regarding current trading prices, PACS is priced at $37.48, while DMAAU trades at $10.58.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

PACS currently has a P/E ratio of 24.21, whereas DMAAU's P/E ratio is N/A. In terms of profitability, PACS's ROE is +0.27%, compared to DMAAU's ROE of +0.04%. Regarding short-term risk, PACS is more volatile compared to DMAAU. This indicates potentially higher risk in terms of short-term price fluctuations for PACS.Check DMAAU's competition here

PACS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, PACS stands at 5.9B. In comparison, OIMAW has a market cap of 250M. Regarding current trading prices, PACS is priced at $37.48, while OIMAW trades at $0.70.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

PACS currently has a P/E ratio of 24.21, whereas OIMAW's P/E ratio is N/A. In terms of profitability, PACS's ROE is +0.27%, compared to OIMAW's ROE of N/A. Regarding short-term risk, PACS is less volatile compared to OIMAW. This indicates potentially lower risk in terms of short-term price fluctuations for PACS.Check OIMAW's competition here

PACS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, PACS stands at 5.9B. In comparison, HCICU has a market cap of 249M. Regarding current trading prices, PACS is priced at $37.48, while HCICU trades at $10.03.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

PACS currently has a P/E ratio of 24.21, whereas HCICU's P/E ratio is 43.05. In terms of profitability, PACS's ROE is +0.27%, compared to HCICU's ROE of -0.78%. Regarding short-term risk, PACS is more volatile compared to HCICU. This indicates potentially higher risk in terms of short-term price fluctuations for PACS.Check HCICU's competition here

PACS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, PACS stands at 5.9B. In comparison, SAAQ has a market cap of 243.8M. Regarding current trading prices, PACS is priced at $37.48, while SAAQ trades at $10.31.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

PACS currently has a P/E ratio of 24.21, whereas SAAQ's P/E ratio is N/A. In terms of profitability, PACS's ROE is +0.27%, compared to SAAQ's ROE of +0.00%. Regarding short-term risk, PACS is more volatile compared to SAAQ. This indicates potentially higher risk in terms of short-term price fluctuations for PACS.Check SAAQ's competition here

PACS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, PACS stands at 5.9B. In comparison, DRDB has a market cap of 242.2M. Regarding current trading prices, PACS is priced at $37.48, while DRDB trades at $10.53.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

PACS currently has a P/E ratio of 24.21, whereas DRDB's P/E ratio is N/A. In terms of profitability, PACS's ROE is +0.27%, compared to DRDB's ROE of +0.03%. Regarding short-term risk, PACS is more volatile compared to DRDB. This indicates potentially higher risk in terms of short-term price fluctuations for PACS.Check DRDB's competition here

PACS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, PACS stands at 5.9B. In comparison, SBXE-UN has a market cap of 241.9M. Regarding current trading prices, PACS is priced at $37.48, while SBXE-UN trades at $10.08.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

PACS currently has a P/E ratio of 24.21, whereas SBXE-UN's P/E ratio is N/A. In terms of profitability, PACS's ROE is +0.27%, compared to SBXE-UN's ROE of -0.03%. Regarding short-term risk, PACS is more volatile compared to SBXE-UN. This indicates potentially higher risk in terms of short-term price fluctuations for PACS.Check SBXE-UN's competition here

PACS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, PACS stands at 5.9B. In comparison, AACO has a market cap of 235.5M. Regarding current trading prices, PACS is priced at $37.48, while AACO trades at $9.90.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

PACS currently has a P/E ratio of 24.21, whereas AACO's P/E ratio is -3106.25. In terms of profitability, PACS's ROE is +0.27%, compared to AACO's ROE of N/A. Regarding short-term risk, PACS is more volatile compared to AACO. This indicates potentially higher risk in terms of short-term price fluctuations for PACS.Check AACO's competition here

PACS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, PACS stands at 5.9B. In comparison, IRHO has a market cap of 235.2M. Regarding current trading prices, PACS is priced at $37.48, while IRHO trades at $9.99.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

PACS currently has a P/E ratio of 24.21, whereas IRHO's P/E ratio is 249.50. In terms of profitability, PACS's ROE is +0.27%, compared to IRHO's ROE of +1.87%. Regarding short-term risk, PACS is more volatile compared to IRHO. This indicates potentially higher risk in terms of short-term price fluctuations for PACS.Check IRHO's competition here

PACS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, PACS stands at 5.9B. In comparison, ILLU has a market cap of 233.2M. Regarding current trading prices, PACS is priced at $37.48, while ILLU trades at $9.87.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

PACS currently has a P/E ratio of 24.21, whereas ILLU's P/E ratio is N/A. In terms of profitability, PACS's ROE is +0.27%, compared to ILLU's ROE of N/A. Regarding short-term risk, PACS is more volatile compared to ILLU. This indicates potentially higher risk in terms of short-term price fluctuations for PACS.Check ILLU's competition here

PACS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, PACS stands at 5.9B. In comparison, CAQ has a market cap of 231.7M. Regarding current trading prices, PACS is priced at $37.48, while CAQ trades at $9.86.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

PACS currently has a P/E ratio of 24.21, whereas CAQ's P/E ratio is N/A. In terms of profitability, PACS's ROE is +0.27%, compared to CAQ's ROE of +9.93%. Regarding short-term risk, PACS is more volatile compared to CAQ. This indicates potentially higher risk in terms of short-term price fluctuations for PACS.Check CAQ's competition here

PACS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, PACS stands at 5.9B. In comparison, VHCP has a market cap of 229.8M. Regarding current trading prices, PACS is priced at $37.48, while VHCP trades at $9.94.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

PACS currently has a P/E ratio of 24.21, whereas VHCP's P/E ratio is N/A. In terms of profitability, PACS's ROE is +0.27%, compared to VHCP's ROE of N/A. Regarding short-term risk, PACS is more volatile compared to VHCP. This indicates potentially higher risk in terms of short-term price fluctuations for PACS.Check VHCP's competition here

PACS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, PACS stands at 5.9B. In comparison, ITHA has a market cap of 229.5M. Regarding current trading prices, PACS is priced at $37.48, while ITHA trades at $9.98.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

PACS currently has a P/E ratio of 24.21, whereas ITHA's P/E ratio is N/A. In terms of profitability, PACS's ROE is +0.27%, compared to ITHA's ROE of +0.00%. Regarding short-term risk, PACS is more volatile compared to ITHA. This indicates potentially higher risk in terms of short-term price fluctuations for PACS.Check ITHA's competition here

PACS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, PACS stands at 5.9B. In comparison, LPCV has a market cap of 229.3M. Regarding current trading prices, PACS is priced at $37.48, while LPCV trades at $9.97.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

PACS currently has a P/E ratio of 24.21, whereas LPCV's P/E ratio is N/A. In terms of profitability, PACS's ROE is +0.27%, compared to LPCV's ROE of +0.00%. Regarding short-term risk, PACS is more volatile compared to LPCV. This indicates potentially higher risk in terms of short-term price fluctuations for PACS.Check LPCV's competition here

PACS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, PACS stands at 5.9B. In comparison, BLRK has a market cap of 229.1M. Regarding current trading prices, PACS is priced at $37.48, while BLRK trades at $9.96.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

PACS currently has a P/E ratio of 24.21, whereas BLRK's P/E ratio is N/A. In terms of profitability, PACS's ROE is +0.27%, compared to BLRK's ROE of N/A. Regarding short-term risk, PACS is more volatile compared to BLRK. This indicates potentially higher risk in terms of short-term price fluctuations for PACS.Check BLRK's competition here

PACS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, PACS stands at 5.9B. In comparison, ADAC has a market cap of 228.8M. Regarding current trading prices, PACS is priced at $37.48, while ADAC trades at $9.93.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

PACS currently has a P/E ratio of 24.21, whereas ADAC's P/E ratio is N/A. In terms of profitability, PACS's ROE is +0.27%, compared to ADAC's ROE of +0.00%. Regarding short-term risk, PACS is more volatile compared to ADAC. This indicates potentially higher risk in terms of short-term price fluctuations for PACS.Check ADAC's competition here

PACS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, PACS stands at 5.9B. In comparison, MEVOU has a market cap of 226.1M. Regarding current trading prices, PACS is priced at $37.48, while MEVOU trades at $10.05.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

PACS currently has a P/E ratio of 24.21, whereas MEVOU's P/E ratio is N/A. In terms of profitability, PACS's ROE is +0.27%, compared to MEVOU's ROE of N/A. Regarding short-term risk, PACS is more volatile compared to MEVOU. This indicates potentially higher risk in terms of short-term price fluctuations for PACS.Check MEVOU's competition here

PACS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, PACS stands at 5.9B. In comparison, SSACU has a market cap of 222.4M. Regarding current trading prices, PACS is priced at $37.48, while SSACU trades at $10.07.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

PACS currently has a P/E ratio of 24.21, whereas SSACU's P/E ratio is N/A. In terms of profitability, PACS's ROE is +0.27%, compared to SSACU's ROE of +0.00%. Regarding short-term risk, PACS is more volatile compared to SSACU. This indicates potentially higher risk in terms of short-term price fluctuations for PACS.Check SSACU's competition here

PACS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, PACS stands at 5.9B. In comparison, PTORU has a market cap of 220.7M. Regarding current trading prices, PACS is priced at $37.48, while PTORU trades at $9.97.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

PACS currently has a P/E ratio of 24.21, whereas PTORU's P/E ratio is N/A. In terms of profitability, PACS's ROE is +0.27%, compared to PTORU's ROE of N/A. Regarding short-term risk, PACS is more volatile compared to PTORU. This indicates potentially higher risk in terms of short-term price fluctuations for PACS.Check PTORU's competition here

PACS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, PACS stands at 5.9B. In comparison, SVAQ has a market cap of 220M. Regarding current trading prices, PACS is priced at $37.48, while SVAQ trades at $9.93.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

PACS currently has a P/E ratio of 24.21, whereas SVAQ's P/E ratio is N/A. In terms of profitability, PACS's ROE is +0.27%, compared to SVAQ's ROE of N/A. Regarding short-term risk, PACS is more volatile compared to SVAQ. This indicates potentially higher risk in terms of short-term price fluctuations for PACS.Check SVAQ's competition here

PACS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, PACS stands at 5.9B. In comparison, GIX has a market cap of 217.8M. Regarding current trading prices, PACS is priced at $37.48, while GIX trades at $9.90.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

PACS currently has a P/E ratio of 24.21, whereas GIX's P/E ratio is N/A. In terms of profitability, PACS's ROE is +0.27%, compared to GIX's ROE of +2.26%. Regarding short-term risk, PACS is more volatile compared to GIX. This indicates potentially higher risk in terms of short-term price fluctuations for PACS.Check GIX's competition here

PACS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, PACS stands at 5.9B. In comparison, DRDBU has a market cap of 210.2M. Regarding current trading prices, PACS is priced at $37.48, while DRDBU trades at $10.51.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

PACS currently has a P/E ratio of 24.21, whereas DRDBU's P/E ratio is N/A. In terms of profitability, PACS's ROE is +0.27%, compared to DRDBU's ROE of +0.03%. Regarding short-term risk, PACS is more volatile compared to DRDBU. This indicates potentially higher risk in terms of short-term price fluctuations for PACS.Check DRDBU's competition here

PACS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, PACS stands at 5.9B. In comparison, TRGSU has a market cap of 209.2M. Regarding current trading prices, PACS is priced at $37.48, while TRGSU trades at $10.03.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

PACS currently has a P/E ratio of 24.21, whereas TRGSU's P/E ratio is N/A. In terms of profitability, PACS's ROE is +0.27%, compared to TRGSU's ROE of N/A. Regarding short-term risk, PACS is more volatile compared to TRGSU. This indicates potentially higher risk in terms of short-term price fluctuations for PACS.Check TRGSU's competition here

PACS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, PACS stands at 5.9B. In comparison, NHIVU has a market cap of 209.1M. Regarding current trading prices, PACS is priced at $37.48, while NHIVU trades at $10.10.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

PACS currently has a P/E ratio of 24.21, whereas NHIVU's P/E ratio is N/A. In terms of profitability, PACS's ROE is +0.27%, compared to NHIVU's ROE of N/A. Regarding short-term risk, PACS is more volatile compared to NHIVU. This indicates potentially higher risk in terms of short-term price fluctuations for PACS.Check NHIVU's competition here

PACS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, PACS stands at 5.9B. In comparison, MUZEU has a market cap of 206.3M. Regarding current trading prices, PACS is priced at $37.48, while MUZEU trades at $10.01.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

PACS currently has a P/E ratio of 24.21, whereas MUZEU's P/E ratio is N/A. In terms of profitability, PACS's ROE is +0.27%, compared to MUZEU's ROE of N/A. Regarding short-term risk, PACS is more volatile compared to MUZEU. This indicates potentially higher risk in terms of short-term price fluctuations for PACS.Check MUZEU's competition here

PACS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, PACS stands at 5.9B. In comparison, TRGS has a market cap of 206.1M. Regarding current trading prices, PACS is priced at $37.48, while TRGS trades at $9.87.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

PACS currently has a P/E ratio of 24.21, whereas TRGS's P/E ratio is N/A. In terms of profitability, PACS's ROE is +0.27%, compared to TRGS's ROE of N/A. Regarding short-term risk, PACS is more volatile compared to TRGS. This indicates potentially higher risk in terms of short-term price fluctuations for PACS.Check TRGS's competition here

PACS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, PACS stands at 5.9B. In comparison, SAC-UN has a market cap of 205M. Regarding current trading prices, PACS is priced at $37.48, while SAC-UN trades at $10.25.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

PACS currently has a P/E ratio of 24.21, whereas SAC-UN's P/E ratio is N/A. In terms of profitability, PACS's ROE is +0.27%, compared to SAC-UN's ROE of +0.00%. Regarding short-term risk, PACS is more volatile compared to SAC-UN. This indicates potentially higher risk in terms of short-term price fluctuations for PACS.Check SAC-UN's competition here

PACS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, PACS stands at 5.9B. In comparison, MUZE has a market cap of 203.7M. Regarding current trading prices, PACS is priced at $37.48, while MUZE trades at $9.88.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

PACS currently has a P/E ratio of 24.21, whereas MUZE's P/E ratio is N/A. In terms of profitability, PACS's ROE is +0.27%, compared to MUZE's ROE of N/A. Regarding short-term risk, PACS is more volatile compared to MUZE. This indicates potentially higher risk in terms of short-term price fluctuations for PACS.Check MUZE's competition here

PACS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, PACS stands at 5.9B. In comparison, DYNCW has a market cap of 201.9M. Regarding current trading prices, PACS is priced at $37.48, while DYNCW trades at $0.13.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

PACS currently has a P/E ratio of 24.21, whereas DYNCW's P/E ratio is -0.18. In terms of profitability, PACS's ROE is +0.27%, compared to DYNCW's ROE of N/A. Regarding short-term risk, PACS is less volatile compared to DYNCW. This indicates potentially lower risk in terms of short-term price fluctuations for PACS.Check DYNCW's competition here

PACS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, PACS stands at 5.9B. In comparison, WLII has a market cap of 201.3M. Regarding current trading prices, PACS is priced at $37.48, while WLII trades at $10.01.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

PACS currently has a P/E ratio of 24.21, whereas WLII's P/E ratio is N/A. In terms of profitability, PACS's ROE is +0.27%, compared to WLII's ROE of N/A. Regarding short-term risk, PACS is more volatile compared to WLII. This indicates potentially higher risk in terms of short-term price fluctuations for PACS.Check WLII's competition here

PACS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, PACS stands at 5.9B. In comparison, XCBEU has a market cap of 200.4M. Regarding current trading prices, PACS is priced at $37.48, while XCBEU trades at $10.02.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

PACS currently has a P/E ratio of 24.21, whereas XCBEU's P/E ratio is N/A. In terms of profitability, PACS's ROE is +0.27%, compared to XCBEU's ROE of N/A. Regarding short-term risk, PACS is more volatile compared to XCBEU. This indicates potentially higher risk in terms of short-term price fluctuations for PACS.Check XCBEU's competition here

PACS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, PACS stands at 5.9B. In comparison, IPEXR has a market cap of 187M. Regarding current trading prices, PACS is priced at $37.48, while IPEXR trades at $0.56.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

PACS currently has a P/E ratio of 24.21, whereas IPEXR's P/E ratio is N/A. In terms of profitability, PACS's ROE is +0.27%, compared to IPEXR's ROE of +0.02%. Regarding short-term risk, PACS is more volatile compared to IPEXR. This indicates potentially higher risk in terms of short-term price fluctuations for PACS.Check IPEXR's competition here

PACS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, PACS stands at 5.9B. In comparison, PAAC has a market cap of 182.1M. Regarding current trading prices, PACS is priced at $37.48, while PAAC trades at $9.91.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

PACS currently has a P/E ratio of 24.21, whereas PAAC's P/E ratio is N/A. In terms of profitability, PACS's ROE is +0.27%, compared to PAAC's ROE of +0.00%. Regarding short-term risk, PACS is more volatile compared to PAAC. This indicates potentially higher risk in terms of short-term price fluctuations for PACS.Check PAAC's competition here

PACS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, PACS stands at 5.9B. In comparison, ETHM has a market cap of 178.8M. Regarding current trading prices, PACS is priced at $37.48, while ETHM trades at $10.77.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

PACS currently has a P/E ratio of 24.21, whereas ETHM's P/E ratio is -13.46. In terms of profitability, PACS's ROE is +0.27%, compared to ETHM's ROE of +0.17%. Regarding short-term risk, PACS is more volatile compared to ETHM. This indicates potentially higher risk in terms of short-term price fluctuations for PACS.Check ETHM's competition here

PACS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, PACS stands at 5.9B. In comparison, AACPU has a market cap of 178.6M. Regarding current trading prices, PACS is priced at $37.48, while AACPU trades at $10.08.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

PACS currently has a P/E ratio of 24.21, whereas AACPU's P/E ratio is N/A. In terms of profitability, PACS's ROE is +0.27%, compared to AACPU's ROE of N/A. Regarding short-term risk, PACS is more volatile compared to AACPU. This indicates potentially higher risk in terms of short-term price fluctuations for PACS.Check AACPU's competition here

PACS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, PACS stands at 5.9B. In comparison, SCII has a market cap of 175.2M. Regarding current trading prices, PACS is priced at $37.48, while SCII trades at $10.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

PACS currently has a P/E ratio of 24.21, whereas SCII's P/E ratio is N/A. In terms of profitability, PACS's ROE is +0.27%, compared to SCII's ROE of N/A. Regarding short-term risk, PACS is more volatile compared to SCII. This indicates potentially higher risk in terms of short-term price fluctuations for PACS.Check SCII's competition here

PACS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, PACS stands at 5.9B. In comparison, SUMA has a market cap of 174.1M. Regarding current trading prices, PACS is priced at $37.48, while SUMA trades at $9.84.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

PACS currently has a P/E ratio of 24.21, whereas SUMA's P/E ratio is N/A. In terms of profitability, PACS's ROE is +0.27%, compared to SUMA's ROE of N/A. Regarding short-term risk, PACS is more volatile compared to SUMA. This indicates potentially higher risk in terms of short-term price fluctuations for PACS.Check SUMA's competition here

PACS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, PACS stands at 5.9B. In comparison, IRAB has a market cap of 171.5M. Regarding current trading prices, PACS is priced at $37.48, while IRAB trades at $9.92.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

PACS currently has a P/E ratio of 24.21, whereas IRAB's P/E ratio is N/A. In terms of profitability, PACS's ROE is +0.27%, compared to IRAB's ROE of -0.14%. Regarding short-term risk, PACS is more volatile compared to IRAB. This indicates potentially higher risk in terms of short-term price fluctuations for PACS.Check IRAB's competition here

PACS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, PACS stands at 5.9B. In comparison, SVCCU has a market cap of 171.5M. Regarding current trading prices, PACS is priced at $37.48, while SVCCU trades at $10.55.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

PACS currently has a P/E ratio of 24.21, whereas SVCCU's P/E ratio is N/A. In terms of profitability, PACS's ROE is +0.27%, compared to SVCCU's ROE of +0.05%. Regarding short-term risk, PACS is more volatile compared to SVCCU. This indicates potentially higher risk in terms of short-term price fluctuations for PACS.Check SVCCU's competition here

PACS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, PACS stands at 5.9B. In comparison, PALO has a market cap of 167.4M. Regarding current trading prices, PACS is priced at $37.48, while PALO trades at $9.87.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

PACS currently has a P/E ratio of 24.21, whereas PALO's P/E ratio is -3183.87. In terms of profitability, PACS's ROE is +0.27%, compared to PALO's ROE of N/A. Regarding short-term risk, PACS is more volatile compared to PALO. This indicates potentially higher risk in terms of short-term price fluctuations for PACS.Check PALO's competition here

PACS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, PACS stands at 5.9B. In comparison, CTAAU has a market cap of 153.8M. Regarding current trading prices, PACS is priced at $37.48, while CTAAU trades at $10.15.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

PACS currently has a P/E ratio of 24.21, whereas CTAAU's P/E ratio is N/A. In terms of profitability, PACS's ROE is +0.27%, compared to CTAAU's ROE of N/A. Regarding short-term risk, PACS is more volatile compared to CTAAU. This indicates potentially higher risk in terms of short-term price fluctuations for PACS.Check CTAAU's competition here

PACS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, PACS stands at 5.9B. In comparison, BSIIU has a market cap of 152.8M. Regarding current trading prices, PACS is priced at $37.48, while BSIIU trades at $9.62.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

PACS currently has a P/E ratio of 24.21, whereas BSIIU's P/E ratio is N/A. In terms of profitability, PACS's ROE is +0.27%, compared to BSIIU's ROE of +0.02%. Regarding short-term risk, PACS is more volatile compared to BSIIU. This indicates potentially higher risk in terms of short-term price fluctuations for PACS.Check BSIIU's competition here

PACS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, PACS stands at 5.9B. In comparison, SUMAU has a market cap of 151.1M. Regarding current trading prices, PACS is priced at $37.48, while SUMAU trades at $10.07.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

PACS currently has a P/E ratio of 24.21, whereas SUMAU's P/E ratio is N/A. In terms of profitability, PACS's ROE is +0.27%, compared to SUMAU's ROE of N/A. Regarding short-term risk, PACS is more volatile compared to SUMAU. This indicates potentially higher risk in terms of short-term price fluctuations for PACS.Check SUMAU's competition here

PACS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, PACS stands at 5.9B. In comparison, TDWD has a market cap of 149.9M. Regarding current trading prices, PACS is priced at $37.48, while TDWD trades at $9.99.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

PACS currently has a P/E ratio of 24.21, whereas TDWD's P/E ratio is N/A. In terms of profitability, PACS's ROE is +0.27%, compared to TDWD's ROE of +0.00%. Regarding short-term risk, PACS is more volatile compared to TDWD. This indicates potentially higher risk in terms of short-term price fluctuations for PACS.Check TDWD's competition here

PACS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, PACS stands at 5.9B. In comparison, SCPQ has a market cap of 136.1M. Regarding current trading prices, PACS is priced at $37.48, while SCPQ trades at $9.94.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

PACS currently has a P/E ratio of 24.21, whereas SCPQ's P/E ratio is N/A. In terms of profitability, PACS's ROE is +0.27%, compared to SCPQ's ROE of N/A. Regarding short-term risk, PACS is more volatile compared to SCPQ. This indicates potentially higher risk in terms of short-term price fluctuations for PACS.Check SCPQ's competition here

PACS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, PACS stands at 5.9B. In comparison, SORNW has a market cap of 135.7M. Regarding current trading prices, PACS is priced at $37.48, while SORNW trades at $0.25.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

PACS currently has a P/E ratio of 24.21, whereas SORNW's P/E ratio is N/A. In terms of profitability, PACS's ROE is +0.27%, compared to SORNW's ROE of +0.00%. Regarding short-term risk, PACS is less volatile compared to SORNW. This indicates potentially lower risk in terms of short-term price fluctuations for PACS.Check SORNW's competition here

PACS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, PACS stands at 5.9B. In comparison, SPHA has a market cap of 111.7M. Regarding current trading prices, PACS is priced at $37.48, while SPHA trades at $10.13.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

PACS currently has a P/E ratio of 24.21, whereas SPHA's P/E ratio is N/A. In terms of profitability, PACS's ROE is +0.27%, compared to SPHA's ROE of -2.76%. Regarding short-term risk, PACS is more volatile compared to SPHA. This indicates potentially higher risk in terms of short-term price fluctuations for PACS.Check SPHA's competition here

PACS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, PACS stands at 5.9B. In comparison, BHAVU has a market cap of 108M. Regarding current trading prices, PACS is priced at $37.48, while BHAVU trades at $10.10.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

PACS currently has a P/E ratio of 24.21, whereas BHAVU's P/E ratio is N/A. In terms of profitability, PACS's ROE is +0.27%, compared to BHAVU's ROE of +0.00%. Regarding short-term risk, PACS is more volatile compared to BHAVU. This indicates potentially higher risk in terms of short-term price fluctuations for PACS.Check BHAVU's competition here

PACS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, PACS stands at 5.9B. In comparison, BHAV has a market cap of 106.1M. Regarding current trading prices, PACS is priced at $37.48, while BHAV trades at $9.92.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

PACS currently has a P/E ratio of 24.21, whereas BHAV's P/E ratio is N/A. In terms of profitability, PACS's ROE is +0.27%, compared to BHAV's ROE of N/A. Regarding short-term risk, PACS is more volatile compared to BHAV. This indicates potentially higher risk in terms of short-term price fluctuations for PACS.Check BHAV's competition here

PACS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, PACS stands at 5.9B. In comparison, SCPQU has a market cap of 104.1M. Regarding current trading prices, PACS is priced at $37.48, while SCPQU trades at $10.06.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

PACS currently has a P/E ratio of 24.21, whereas SCPQU's P/E ratio is N/A. In terms of profitability, PACS's ROE is +0.27%, compared to SCPQU's ROE of N/A. Regarding short-term risk, PACS is more volatile compared to SCPQU. This indicates potentially higher risk in terms of short-term price fluctuations for PACS.Check SCPQU's competition here

PACS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, PACS stands at 5.9B. In comparison, RFAMU has a market cap of 103.1M. Regarding current trading prices, PACS is priced at $37.48, while RFAMU trades at $9.97.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

PACS currently has a P/E ratio of 24.21, whereas RFAMU's P/E ratio is N/A. In terms of profitability, PACS's ROE is +0.27%, compared to RFAMU's ROE of N/A. Regarding short-term risk, PACS is more volatile compared to RFAMU. This indicates potentially higher risk in terms of short-term price fluctuations for PACS.Check RFAMU's competition here

PACS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, PACS stands at 5.9B. In comparison, CHPG has a market cap of 103.1M. Regarding current trading prices, PACS is priced at $37.48, while CHPG trades at $10.32.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

PACS currently has a P/E ratio of 24.21, whereas CHPG's P/E ratio is 57.33. In terms of profitability, PACS's ROE is +0.27%, compared to CHPG's ROE of +0.03%. Regarding short-term risk, PACS is more volatile compared to CHPG. This indicates potentially higher risk in terms of short-term price fluctuations for PACS.Check CHPG's competition here

PACS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, PACS stands at 5.9B. In comparison, NOEM has a market cap of 99.9M. Regarding current trading prices, PACS is priced at $37.48, while NOEM trades at $10.42.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

PACS currently has a P/E ratio of 24.21, whereas NOEM's P/E ratio is 61.29. In terms of profitability, PACS's ROE is +0.27%, compared to NOEM's ROE of +0.02%. Regarding short-term risk, PACS is more volatile compared to NOEM. This indicates potentially higher risk in terms of short-term price fluctuations for PACS.Check NOEM's competition here